Where can I find WHWK's financial statements?

Whitehawk Therapeutics Inc (WHWK)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for WHWK?

Whitehawk Therapeutics Inc (WHWK) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does WHWK update its statements?

Whitehawk Therapeutics Inc files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

WHWK

Whitehawk Therapeutics Inc

NASDAQ·Biotechnology · Healthcare

$4.84$0.24−4.72%

After hours·$5.00+3.31%

Market cap$275.92M·Market closed·Aug 26 8:00 PM UTC

USD · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Revenue	$1.12M−92.3%	$15.22M+1,258.6%	$24.35M+60.1%	$25.98M+6.7%	$7.15M−72.5%
Cost of revenue	$19.67M+31.1%	$34.00M+72.8%	$51.74M+52.2%	$54.05M+4.5%	$760.00K−98.6%
Gross profit	−$18.55M−4,234.1%	−$18.78M−1.2%	−$27.38M−45.8%	−$28.07M−2.5%	$6.39M+122.7%
Research & development	$19.67M+31.1%	$32.66M+66.0%	$48.93M+49.8%	$51.03M+4.3%	$90.96M+78.3%
General & administrative	$18.51M+772.7%	—	—	—	—
SG&A (combined)	$18.51M+772.7%	$40.18M+117.0%	$44.55M+10.9%	$36.75M−17.5%	$29.82M−18.8%
Other operating expenses	$54.49M+463.0%	−$28.94M−153.1%	−$48.93M−69.1%	−$48.39M+1.1%	—
Total operating expenses	$92.67M+4,269.0%	$43.90M−52.6%	$44.55M+1.5%	$39.39M−11.6%	$120.79M+206.7%
Operating income	−$111.22M−4,263.2%	−$62.68M+43.6%	−$71.93M−14.8%	−$67.46M+6.2%	−$114.40M−69.6%
Interest income	$13.00K−68.3%	$2.40M+18,346.2%	$6.40M+166.9%	$3.93M−38.7%	$6.23M+58.8%
Interest expense	$665.00K−18.4%	$230.00K−65.4%	$231.00K+0.4%	$154.00K−33.3%	—
Other income / (expense), net	$1.13M+221.8%	$2.17M+92.0%	$6.17M+184.5%	$3.77M−38.9%	$93.80M+2,390.2%
Income before tax	−$110.09M−3,067.1%	−$60.51M+45.0%	−$65.77M−8.7%	−$63.69M+3.2%	−$20.60M+67.7%
Income tax expense	$2.00K+0.0%	—	—	—	—
Net income	−$110.09M−3,065.3%	−$60.51M+45.0%	−$65.77M−8.7%	−$63.69M+3.2%	−$20.60M+67.7%

EPS (basic)	−$12.41−5,809.5%	−$2.69+78.3%	−$2.44+9.3%	−$2.36+3.3%	−$0.33+86.0%
EPS (diluted)	−$12.41−5,809.5%	−$2.69+78.3%	−$2.44+9.3%	−$2.36+3.3%	−$0.33+86.0%
Weighted avg shares (basic)	8,871,233	22,511,000	26,918,000	27,030,000	61,886,765
Weighted avg shares (diluted)	8,923,369	22,511,000	26,918,000	27,030,000	61,886,765

Depreciation & amortization	$105.00K+1,066.7%	$159.00K+51.4%	$169.00K+6.3%	$193.00K+14.2%	$79.00K−59.1%
EBITDA	−$36.96M−1,355.0%	−$58.80M−59.1%	−$65.37M−11.2%	−$64.63M+1.1%	−$20.52M+68.3%

Frequently Asked Questions About WHWK

Where can I find WHWK's financial statements?: Whitehawk Therapeutics Inc (WHWK)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for WHWK?: Whitehawk Therapeutics Inc (WHWK) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does WHWK update its statements?: Whitehawk Therapeutics Inc files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

Line item

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Trend

Revenue

$1.12M−92.3%

$15.22M+1,258.6%

$24.35M+60.1%

$25.98M+6.7%

$7.15M−72.5%

Cost of revenue

$19.67M+31.1%

$34.00M+72.8%

$51.74M+52.2%

$54.05M+4.5%

$760.00K−98.6%

Gross profit

−$18.55M−4,234.1%

−$18.78M−1.2%

−$27.38M−45.8%

−$28.07M−2.5%

$6.39M+122.7%

Research & development

$19.67M+31.1%

$32.66M+66.0%

$48.93M+49.8%

$51.03M+4.3%

$90.96M+78.3%

General & administrative

$18.51M+772.7%

—

SG&A (combined)

$18.51M+772.7%

$40.18M+117.0%

$44.55M+10.9%

$36.75M−17.5%

$29.82M−18.8%

Other operating expenses

$54.49M+463.0%

−$28.94M−153.1%

−$48.93M−69.1%

−$48.39M+1.1%

—

Total operating expenses

$92.67M+4,269.0%

$43.90M−52.6%

$44.55M+1.5%

$39.39M−11.6%

$120.79M+206.7%

Operating income

−$111.22M−4,263.2%

−$62.68M+43.6%

−$71.93M−14.8%

−$67.46M+6.2%

−$114.40M−69.6%

Interest income

$13.00K−68.3%

$2.40M+18,346.2%

$6.40M+166.9%

$3.93M−38.7%

$6.23M+58.8%

Interest expense

$665.00K−18.4%

$230.00K−65.4%

$231.00K+0.4%

$154.00K−33.3%

—

Other income / (expense), net

$1.13M+221.8%

$2.17M+92.0%

$6.17M+184.5%

$3.77M−38.9%

$93.80M+2,390.2%

Income before tax

−$110.09M−3,067.1%

−$60.51M+45.0%

−$65.77M−8.7%

−$63.69M+3.2%

−$20.60M+67.7%

Income tax expense

$2.00K+0.0%

—

Net income

−$110.09M−3,065.3%

−$60.51M+45.0%

−$65.77M−8.7%

−$63.69M+3.2%

−$20.60M+67.7%

EPS (basic)

−$12.41−5,809.5%

−$2.69+78.3%

−$2.44+9.3%

−$2.36+3.3%

−$0.33+86.0%

EPS (diluted)

−$12.41−5,809.5%

−$2.69+78.3%

−$2.44+9.3%

−$2.36+3.3%

−$0.33+86.0%

Weighted avg shares (basic)

8,871,233

22,511,000

26,918,000

27,030,000

61,886,765

Weighted avg shares (diluted)

8,923,369

22,511,000

26,918,000

27,030,000

61,886,765

Depreciation & amortization

$105.00K+1,066.7%

$159.00K+51.4%

$169.00K+6.3%

$193.00K+14.2%

$79.00K−59.1%

EBITDA

−$36.96M−1,355.0%

−$58.80M−59.1%

−$65.37M−11.2%

−$64.63M+1.1%

−$20.52M+68.3%